electroCore, Inc.
ECOR4.740USD
-0.210-4.24%
Cierre 11/05, 16:00（ET）Cotizaciones retrasadas 15 min
35.39MCap. mercado
PérdidaP/E TTM
Más Datos de electroCore, Inc. Compañía
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.
Información de electroCore, Inc.
Símbolo de cotizaciónECOR
Nombre de la empresaelectroCore, Inc.
Fecha de salida a bolsaJun 22, 2018
Director ejecutivoMr. Daniel S. Goldberger
Número de empleados73
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 22
Dirección200 Forge Way
CiudadROCKAWAY
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal07866
Teléfono19732900097
Sitio Webhttps://www.electrocore.com/
Símbolo de cotizaciónECOR
Fecha de salida a bolsaJun 22, 2018
Director ejecutivoMr. Daniel S. Goldberger
Ejecutivos de electroCore, Inc.
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
184.90K
+0.54%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+22.69%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+27.52%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+35.66%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
--
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joshua S. Lev
Mr. Joshua S. Lev
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Julie A. Goldstein
Ms. Julie A. Goldstein
Independent Director
Independent Director
--
--
Mr. James C. Theofilos
Mr. James C. Theofilos
Director
Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
184.90K
+0.54%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+22.69%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+27.52%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+35.66%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
--
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Rx gammaCore - Department of Veteran Affairs and Department of Defense
5.18M
70.25%
Truvaga
994.00K
13.47%
Outside the United States
465.00K
6.30%
Rx gammaCore - U.S. Commercial
394.00K
5.34%
TAC-STIM
181.00K
2.45%
Otro
162.00K
2.19%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
6.89M
93.42%
United Kingdom
433.00K
5.87%
Other
36.00K
0.49%
Japan
17.00K
0.23%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Rx gammaCore - Department of Veteran Affairs and Department of Defense
5.18M
70.25%
Truvaga
994.00K
13.47%
Outside the United States
465.00K
6.30%
Rx gammaCore - U.S. Commercial
394.00K
5.34%
TAC-STIM
181.00K
2.45%
Otro
162.00K
2.19%
Estadísticas de accionistas
Actualizado: dom., 14 de sep
Actualizado: dom., 14 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
AWM Investment Company, Inc.
3.38%
Otro
72.64%
Accionistas
Accionistas
Proporción
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
AWM Investment Company, Inc.
3.38%
Otro
72.64%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
26.98%
Corporation
8.76%
Investment Advisor
7.19%
Investment Advisor/Hedge Fund
4.70%
Hedge Fund
2.52%
Research Firm
0.24%
Pension Fund
0.03%
Otro
49.58%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
70
1.17M
14.68%
-263.78K
2025Q2
83
3.54M
47.26%
+919.62K
2025Q1
79
2.97M
41.24%
+583.46K
2024Q4
81
2.54M
38.89%
+127.67K
2024Q3
72
2.68M
41.45%
+353.98K
2024Q2
75
2.58M
42.20%
+349.71K
2024Q1
80
2.10M
35.02%
-224.03K
2023Q4
78
2.23M
37.11%
+633.96K
2023Q3
84
2.11M
37.42%
+276.86K
2023Q2
89
1.49M
31.36%
-816.60K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Zhang (Tianyi)
734.64K
9.25%
+734.64K
--
May 15, 2025
Theofilos (Charles Steve)
444.53K
5.6%
--
--
Jul 04, 2025
Hilve Holdings Ltd
432.00K
5.44%
+432.00K
--
Aug 15, 2025
Errico (Thomas J.)
306.38K
3.86%
+26.61K
+9.51%
Sep 02, 2025
AWM Investment Company, Inc.
269.93K
3.4%
-48.18K
-15.15%
Jun 30, 2025
The Vanguard Group, Inc.
232.33K
2.92%
--
--
Jun 30, 2025
Goldberger (Daniel S)
184.90K
2.33%
+1.00K
+0.54%
Aug 11, 2025
Renaissance Technologies LLC
180.69K
2.27%
+2.26K
+1.27%
Jun 30, 2025
Happy Holstein Management, LLC
153.17K
1.93%
--
--
Jul 04, 2025
MAZ Partners, L.P.
115.52K
1.45%
-156.44K
-57.52%
May 13, 2025
Ver más
ETFs relacionados
Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
Proporción0.01%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Fecha
Tipo
Relación
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
